DNMT3A and cancer: Upon treatment of the different cancer cell lines (HaCaT, HepG2, and A549 cells) with TRZ in our study, DNMT1, DNMT3a, and DNMT3b were significantly upregulated at concentrations of 20, 40, and 80 μM for a duration of 24 h.